More MS news articles for December 2002

Individuals diagnosed with multiple sclerosis and have a history of pathological laughing and/or crying (pseudobulbar affect).

http://www.msfacts.org/newsthismonth.htm

[I cannot find any reference to the actual name of this trial drug.]

A clinical research study to assess the safety and effectiveness of a study drug which may alleviate the symptoms of pathological laughing and/or crying (pseudobulbar affect) in individuals with multiple sclerosis (MS).

Inclusion Criteria:

The subject must be 18 to 68 years of age.
The subject must have a confirmed diagnosis of multiple sclerosis or probably multiple sclerosis.
The subject must have a clinical history of pseudobulbar affect (pathological laughing and/or crying).
Female subjects must be using a medically accepted means of contraception.

Exclusion Criteria:

Female subjects who are either pregnant or nursing.
Subjects with myasthenia gravis.
Subjects with ventricular tachycardia or torsades de pointes.
Subjects with current or prior history of major psychiatric disturbance.

Neurologists from the following locations will be participating and recruiting from within their communities:

Canton, Ohio
Decatur, Georgia
Raleigh, North Carolina
Seattle, Washington
Upland and Allentown, Pennsylvania
Albany and Syracuse, New York
Northbrook, Illinois
Madison, Wisconsin
Washington, D.C.
San Francisco, California
Burlington, Vermont
Miami, Florida
Phoenix, Arizona

If you are interested in learning more about this study or becoming a participant, please contact:

Vickie T. Anderson, Investigator and Patient Services Specialist